Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
DEL PRIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionNeuberger Berman Group LLC
Latest Disclosed Ownership9,876 shares
Latest Disclosed Value $ 230,111
Neuberger Berman Group LLC ownership in HVE / Innoviva, Inc.

On May 14, 2026 - Neuberger Berman Group LLC filed a 13F-HR form disclosing ownership of 9,876 shares of Innoviva, Inc. (DE:HVE) valued at $197,520 USD as of March 31, 2026. The entity filed a previous 13F-HR on November 12, 2025 disclosing 0 shares of Innoviva, Inc.. The current value of the position is $189,619 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F INNOVIVA Common 45781M101 9,876 9,876 230 0.0001
2025-11-12 2025-09-30 13F INNOVIVA Common 45781M101 0 -11,068 -100.00 0 -100.00
2025-08-25 2025-06-30 13F/A-1 INNOVIVA Common 45781M101 11,068 11,068 222 0.0002
2025-08-13 2025-06-30 13F INNOVIVA Common 45781M101 11,068 11,068 222 0.0001
2021-08-13 2021-06-30 13F INNOVIVA Common 45781M101 0 -56,510 -100.00 0 -100.00
2021-05-13 2021-03-31 13F INNOVIVA Common 45781M101 56,510 0 0.00 675 -3.57 0.0006
2021-02-10 2020-12-31 13F INNOVIVA Common 45781M101 56,510 -25 -0.04 700 18.44 0.0007
2020-11-12 2020-09-30 13F INNOVIVA Common 45781M101 56,535 0 0.00 591 -25.19 0.0007
2020-08-13 2020-06-30 13F INNOVIVA Common 45781M101 56,535 56,535 790 0.0010
2014-11-04 2014-09-30 13F THERAVANCE COMMON STOCK 88338T104 0 -16,945 -100.00 0 -100.00
2014-08-05 2014-06-30 13F THERAVANCE COMMON STOCK 88338T104 16,945 16,945 505 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.